Riboflavin/ultraviolet a corneal collagen cross-linking for the treatment of keratoconus

Visual outcomes and scheimpflug analysis

Maria A. Henriquez, Luis Izquierdo, Cesar Bernilla, Peter A. Zakrzewski, Mark J Mannis

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Purpose: To evaluate the safety and efficacy of corneal collagen cross-linking (CXL) by riboflavin/UV light for the treatment of keratoconus. Methods: This randomized, prospective, and comparative study involved 10 eyes with keratoconus diagnosed between September 2006 and January 2008. Each patient underwent CXL in the keratoconus eye. Preoperative and postoperative (at 1, 3, 6, and 12 months) biomicroscopy examinations, distance uncorrected and best-corrected visual acuities, refractive error, endothelial cell counts, keratometry readings, ultrasound pachymetry, macular thickness, and Scheimpflug analyses were performed and compared. Results: Mean uncorrected visual acuity was 1.18 logarithm of the minimum angle of resolution preoperatively and 0.46 logarithm of the minimum angle of resolution at 12 months postoperatively (P < 0.001). Statistically significant reductions in the mean maximum [2.66 diopter (D), P = 0.04] and minimum (1.61 D, P = 0.03) keratometry values were present at 12 months postoperatively, in addition there was a 2.25 D reduction in the mean spherical equivalent (P = 0.01). At the end of follow-up, 8 (80%) and 6 (60%) of the 10 eyes showed a decrease in the anterior and posterior elevation values, respectively, and the thinnest point of the cornea was statistically thinner by a mean of 13.4 μm (P = 0.03). No statistically significant differences were found between preoperative and postoperative endothelial cell counts and macular thicknesses. The improvements in visual acuity, keratometry readings, and spherical equivalent values occurred progressively during follow-up. Conclusions: CXL procedure is a safe treatment for keratoconus, yields good visual results, and reduces the progression of the disease, but long follow-up is necessary.

Original languageEnglish (US)
Pages (from-to)281-286
Number of pages6
JournalCornea
Volume30
Issue number3
DOIs
StatePublished - Mar 2011

Fingerprint

Keratoconus
Riboflavin
Collagen
Visual Acuity
Reading
Endothelial Cells
Cell Count
Refractive Errors
Therapeutics
Ultraviolet Rays
Cornea
Disease Progression
Prospective Studies
Safety

Keywords

  • corneal collagen cross-linking
  • keratoconus

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Riboflavin/ultraviolet a corneal collagen cross-linking for the treatment of keratoconus : Visual outcomes and scheimpflug analysis. / Henriquez, Maria A.; Izquierdo, Luis; Bernilla, Cesar; Zakrzewski, Peter A.; Mannis, Mark J.

In: Cornea, Vol. 30, No. 3, 03.2011, p. 281-286.

Research output: Contribution to journalArticle

Henriquez, Maria A. ; Izquierdo, Luis ; Bernilla, Cesar ; Zakrzewski, Peter A. ; Mannis, Mark J. / Riboflavin/ultraviolet a corneal collagen cross-linking for the treatment of keratoconus : Visual outcomes and scheimpflug analysis. In: Cornea. 2011 ; Vol. 30, No. 3. pp. 281-286.
@article{461f7fa116be4b7694d50a1c2eb9006e,
title = "Riboflavin/ultraviolet a corneal collagen cross-linking for the treatment of keratoconus: Visual outcomes and scheimpflug analysis",
abstract = "Purpose: To evaluate the safety and efficacy of corneal collagen cross-linking (CXL) by riboflavin/UV light for the treatment of keratoconus. Methods: This randomized, prospective, and comparative study involved 10 eyes with keratoconus diagnosed between September 2006 and January 2008. Each patient underwent CXL in the keratoconus eye. Preoperative and postoperative (at 1, 3, 6, and 12 months) biomicroscopy examinations, distance uncorrected and best-corrected visual acuities, refractive error, endothelial cell counts, keratometry readings, ultrasound pachymetry, macular thickness, and Scheimpflug analyses were performed and compared. Results: Mean uncorrected visual acuity was 1.18 logarithm of the minimum angle of resolution preoperatively and 0.46 logarithm of the minimum angle of resolution at 12 months postoperatively (P < 0.001). Statistically significant reductions in the mean maximum [2.66 diopter (D), P = 0.04] and minimum (1.61 D, P = 0.03) keratometry values were present at 12 months postoperatively, in addition there was a 2.25 D reduction in the mean spherical equivalent (P = 0.01). At the end of follow-up, 8 (80{\%}) and 6 (60{\%}) of the 10 eyes showed a decrease in the anterior and posterior elevation values, respectively, and the thinnest point of the cornea was statistically thinner by a mean of 13.4 μm (P = 0.03). No statistically significant differences were found between preoperative and postoperative endothelial cell counts and macular thicknesses. The improvements in visual acuity, keratometry readings, and spherical equivalent values occurred progressively during follow-up. Conclusions: CXL procedure is a safe treatment for keratoconus, yields good visual results, and reduces the progression of the disease, but long follow-up is necessary.",
keywords = "corneal collagen cross-linking, keratoconus",
author = "Henriquez, {Maria A.} and Luis Izquierdo and Cesar Bernilla and Zakrzewski, {Peter A.} and Mannis, {Mark J}",
year = "2011",
month = "3",
doi = "10.1097/ICO.0b013e3181eeaea1",
language = "English (US)",
volume = "30",
pages = "281--286",
journal = "Cornea",
issn = "0277-3740",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Riboflavin/ultraviolet a corneal collagen cross-linking for the treatment of keratoconus

T2 - Visual outcomes and scheimpflug analysis

AU - Henriquez, Maria A.

AU - Izquierdo, Luis

AU - Bernilla, Cesar

AU - Zakrzewski, Peter A.

AU - Mannis, Mark J

PY - 2011/3

Y1 - 2011/3

N2 - Purpose: To evaluate the safety and efficacy of corneal collagen cross-linking (CXL) by riboflavin/UV light for the treatment of keratoconus. Methods: This randomized, prospective, and comparative study involved 10 eyes with keratoconus diagnosed between September 2006 and January 2008. Each patient underwent CXL in the keratoconus eye. Preoperative and postoperative (at 1, 3, 6, and 12 months) biomicroscopy examinations, distance uncorrected and best-corrected visual acuities, refractive error, endothelial cell counts, keratometry readings, ultrasound pachymetry, macular thickness, and Scheimpflug analyses were performed and compared. Results: Mean uncorrected visual acuity was 1.18 logarithm of the minimum angle of resolution preoperatively and 0.46 logarithm of the minimum angle of resolution at 12 months postoperatively (P < 0.001). Statistically significant reductions in the mean maximum [2.66 diopter (D), P = 0.04] and minimum (1.61 D, P = 0.03) keratometry values were present at 12 months postoperatively, in addition there was a 2.25 D reduction in the mean spherical equivalent (P = 0.01). At the end of follow-up, 8 (80%) and 6 (60%) of the 10 eyes showed a decrease in the anterior and posterior elevation values, respectively, and the thinnest point of the cornea was statistically thinner by a mean of 13.4 μm (P = 0.03). No statistically significant differences were found between preoperative and postoperative endothelial cell counts and macular thicknesses. The improvements in visual acuity, keratometry readings, and spherical equivalent values occurred progressively during follow-up. Conclusions: CXL procedure is a safe treatment for keratoconus, yields good visual results, and reduces the progression of the disease, but long follow-up is necessary.

AB - Purpose: To evaluate the safety and efficacy of corneal collagen cross-linking (CXL) by riboflavin/UV light for the treatment of keratoconus. Methods: This randomized, prospective, and comparative study involved 10 eyes with keratoconus diagnosed between September 2006 and January 2008. Each patient underwent CXL in the keratoconus eye. Preoperative and postoperative (at 1, 3, 6, and 12 months) biomicroscopy examinations, distance uncorrected and best-corrected visual acuities, refractive error, endothelial cell counts, keratometry readings, ultrasound pachymetry, macular thickness, and Scheimpflug analyses were performed and compared. Results: Mean uncorrected visual acuity was 1.18 logarithm of the minimum angle of resolution preoperatively and 0.46 logarithm of the minimum angle of resolution at 12 months postoperatively (P < 0.001). Statistically significant reductions in the mean maximum [2.66 diopter (D), P = 0.04] and minimum (1.61 D, P = 0.03) keratometry values were present at 12 months postoperatively, in addition there was a 2.25 D reduction in the mean spherical equivalent (P = 0.01). At the end of follow-up, 8 (80%) and 6 (60%) of the 10 eyes showed a decrease in the anterior and posterior elevation values, respectively, and the thinnest point of the cornea was statistically thinner by a mean of 13.4 μm (P = 0.03). No statistically significant differences were found between preoperative and postoperative endothelial cell counts and macular thicknesses. The improvements in visual acuity, keratometry readings, and spherical equivalent values occurred progressively during follow-up. Conclusions: CXL procedure is a safe treatment for keratoconus, yields good visual results, and reduces the progression of the disease, but long follow-up is necessary.

KW - corneal collagen cross-linking

KW - keratoconus

UR - http://www.scopus.com/inward/record.url?scp=79951774510&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951774510&partnerID=8YFLogxK

U2 - 10.1097/ICO.0b013e3181eeaea1

DO - 10.1097/ICO.0b013e3181eeaea1

M3 - Article

VL - 30

SP - 281

EP - 286

JO - Cornea

JF - Cornea

SN - 0277-3740

IS - 3

ER -